Inso Biosciences is an early-stage Ithaca, New York biotechnology company building hardware and tools for genomic sample preparation. Its patented microfluidic 'micropillar' technology, invented and developed at Cornell University, captures DNA physically rather than through traditional affinity binding, extracting high molecular weight DNA from raw cells, blood, or tissue in 8-10 minutes. The company targets long-read DNA sequencing, multi-omic sample processing, and pathogen surveillance. It was founded around 2020 and has backing from investors including SOSV, Whitecap Venture Partners, Ataraxia, and CRCM Ventures, alongside non-dilutive New York State and federal awards.